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Abstract
Baicalin (BC) has been used for cancer therapy due to its multiple effects as an anti-cancer drug. However, the
effective delivery of this molecule to targeted cells is difficult. Gold nanoparticles (AuNPs) conjugated with thiolated
beta cyclodextrin (AuNP-S-β-CD) were used as a delivery vector in this study. Cell viability tests were evaluated by
cell counting kit-8 (CCK) and live/dead cell assay. To demonstrate the proliferation inhibition effect on Michigan
Cancer Foundation-7 (MCF-7) cells by BC, we analyzed using Hoechst 33342 staining assay and gel electrophoresis.
The S-β-CD conjugated AuNPs were characterized by transmission electron microscopy (TEM), 1H nuclear magnetic
resonance (1H NMR), and ultraviolet visible (UV-vis) spectroscopy. AuNP-S-β-CD with approximately 40 μM of BC
loaded by inclusion complex showed an inhibition effect on MCF-7 cells by inducing apoptosis. Apoptosis test
results were evaluated by analyzing the expression of typical apoptic markers such as cleaved caspase-3, full length
caspase-3, and apaf-1 in western blot assay. These results demonstrated that AuNP-S-β-CD-BC inhibited the
proliferation of cancerous MCF-7 cells by inducing apoptosis. These findings suggested that AuNP-S-β-CD-BC could
be a promising agent for chemotherapeutic usage.
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Background
Breast cancer is one of the most common forms of can-
cer in women in the world. The rate of breast cancer in-
cidence is increasing rapidly because of changes in diet,
breastfeeding methods, and the environment. Many
kinds of therapy have been tried for treatment of breast
cancer [1]. The most successful treatments have been
chemotherapy and radiotherapy. However, these therap-
ies are often accompanied by side-effects [2, 3].
In order to alleviate these adverse side-effects, studies
are actively underway to develop naturally based treat-
ments for breast cancer [4–7]. Scutellaria baicalensis
Georgi (SB), a common medicinal herb, contains various
flavonoids such as baicalin (BC), baicalein, wogonin,
wogonoside, oroxylin A, and oroxylin A-7. These are
well-known constituents which contribute to SB bio-
logical activity [8]. Especially, BC and baicalein have
been reported for inhibition of cancer proliferation as
well as inducing apoptosis of cancer cells [9–12]. BC has
useful properties for use as a drug; however, it is difficult
to deliver BC in a targeted fashion towards cancer cells.
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Recently, in the biomaterials research field, gold
nanoparticles (AuNPs) bearing moieties which target
receptors on the cell surface have been used for delivery
of materials into cells through endocytosis [13–16]. In
addition, immune cells containing AuNPs were used to
utilize in cancer therapy field [17–20]. According to
Albanese and Chan, AuNPs have no cytotoxicity and
have a great capacity for cellular uptake [21]. Further-
more, biological drugs such as proteins, DNA, and RNA
have been investigated as materials that can be delivered
via various sizes of AuNPs or gold nanorods [22–29].
In this study, we designed a functionalized AuNPs
modified using thiolated beta-cyclodextrin (AuNP-S-β-
CD) as a means to load BC. Cell counting and western
blot assays were conducted to prove the anti-cancer
effectiveness of AuNP-S-β-CD-BC. Michigan Cancer
Foundation-7 (MCF-7) cells, which are typical breast
cancer cells, were used in all the cellular tests.
Methods
Gold (III) chloride hydrate (99.999 % trace metals basis),
sodium citrate, iodine, beta cyclodextrin, sodium meth-
oxide, baicalin, and Hoechst 33342 stain were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s
modified eagle medium (DMEM), fetal bovine serum
(FBS), penicillin streptomycin (Pen strep), and Dulbecco’s
phosphate-buffered saline (DPBS) were purchased from
GIBCO BRL (Invitrogen Co., USA). Antibody for β-actin
was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Antibodies for cleaved caspase-3, full-
length caspase-3, and apaf-1 were purchased from Cell
Signaling Technology (Beverly, MA, USA).
MCF-7 cells were purchased from Invitrogen (Carlsbad,
CA, USA) and cultured in a tissue culture plate filled with
DMEM (containing 1 % PS and 10 % FBS) in a 37 °C
heated-humidified atmosphere with 5 % CO2. MCF-7 cells
were seeded into 24-well plates (1 × 105 cells/well) and
incubated for 24 and 48 h, respectively. At each prede-
termined timepoint, the optical densities of the cells were
evaluated by using a cell counting kit-8 (CCK, Dojindo,
Kumamoto, Japan). In order to quantify, we measured the
cell viability percentage amongst all groups. The intensity
was measured by a microplate reader (BioRad, USA) at a
wavelength of 450 nm. The live/dead cell assay kit, including
calcein-AM/ethidium homodimer-1 (EthD-1) was used to
demonstrate the inhibition effect of BC qualitatively.
MCF-7 cells were seeded at a density of 2 × 105 cells/
well in a medium containing 100 μM of BC for Hoechst
33342 and DNA fragmentation assay. After 2 days, the
cells were stained with Hoechst 33342 solution for 1 h
in a 37 °C heated-humidified atmosphere with 5 % CO2,
and were then observed by a fluorescent microscope
(Olympus IX71, Japan). For DNA fragmentation assay,
the cells were lysed by using a lysis buffer containing a
protease inhibitor. A total of 250 μg of gDNA was ex-
tracted from each group using a gDNA purification kit
(Taiwan). The gDNA was tested using gel electrophor-
esis in a 2 % agarose gel and measured by ChemiDoc
XRS System (Bio-Rad, Hercules, CA, USA).
AuNPs were produced by reducing gold chloride hy-
drate as previously described [30]. Briefly, 0.02 % gold
chloride hydrate solution (800 ml) was boiled to 100 °C
under a reflux condenser, and 2 % sodium citrate solu-
tion (15 ml) was added into the gold chloride hydrate
solution. The mixed solution reaction changed color to
dark purple. The temperature was held for 15 min and
then allowed to cool gradually to room temperature. S-
β-CD was prepared as described in our previous study
[31]; 50 μM of BC and 50 μM of AuNP-S-β-CD were
mixed and ultra-sonicated for 5 min to load the BC into
the β-CD. The loading volume of BC on AuNP-S-β-CD
was calculated by comparing the optical density of the
BC solution group with the AuNP-S-β-CD-BC solution
group. The synthesized/conjugated materials were ana-
lyzed by transmission electron microscopy (TEM) (H-
7100, Hitachi, Japan), 1H nuclear magnetic resonance
spectrometer (1H NMR spectrometer, INOVA400, CA,
USA), and ultraviolet visible (UV-vis) spectroscopy
(1650PC spectrophotometer, Shimadzu, Japan).
MCF-7 cells were seeded at a density of 1 × 105 cells/
well with a medium-containing AuNP-S-β-CD and
AuNP-S-β-CD-BC in 6-well plates and incubated for 24
and 48 h, respectively. At the predetermined hour, MCF-
7 cells were lysed by the addition of cold RIPA lysis buf-
fer containing 0.5 M Tris-HCl, pH 7.4, 1.5 M NaCl,
2.5 % deoxycholic acid, 10 % NP-40, and 10 mM EDTA
along with protease and phosphatase inhibitors. The cell
lysates were incubated in an ice box for 30 min and then
centrifuged at 1.3 × 104 rpm for 10 min. Aliquots of
40 μg of equal amounts of protein was added into so-
dium dodecyl sulfate and loaded into polyacrylamide gel
for electrophoreses (SDS-PAGE). These were subsequently
transferred using a nitrocellulose transfer membrane.
After blocking the nitrocellulose transfer membrane with
5 % skim milk, the membrane was probed with cleaved
caspase-3, full-length caspase-3, apaf-1, and β-actin
followed by incubation with an appropriate secondary
antibody conjugated to horseradish peroxidase. Signals
were detected using a ChemiDoc XRS System (Bio-Rad),
and β-actin was regarded as an internal control group.
Statistical analysis was performed using Student’s t test.
All values were expressed as means ± standard deviations,
and all the experimental groups compared with the
control group.
Results and Discussion
We performed a cell viability test in order to confirm
the anti-cancer effectiveness of BC. The proliferation
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inhibitory rate was evaluated using a microplate leader.
Cells were treated with various concentrations of BC (1,
10, 50, 100, and 200 μM) and were measured at 24 and
48 h, respectively. After 24 h, the results of the cell via-
bility test demonstrated cell viability at 101, 91, 79, 64,
and 46 % for doses of 1, 10, 50, 100, and 200 μM BC, re-
spectively (Fig. 1a). After 48 h of incubation, the viability
of each group was further reduced as compared with the
24-h groups. The live/dead cell assay also showed that
BC inhibited MCF-7 proliferation in a dose-dependent
manner. Especially, almost all MCF-7 cells were dead
when exposed to doses greater than 100 μM of BC
(Fig. 1b).
Hoechst 33342 staining and DNA fragmentation assay
were carried out to analyze the BC-induced apoptosis
effect (Fig. 2). In the fluorescence microscopic image,
100-μM BC-treated cells showed significantly higher nu-
clear fragmentation which confirms apoptosis (Fig. 2b).
Figure 2c shows the “ladder-shape” DNA fragmentation
which also indicates DNA apoptosis [32]. These results
show that apoptosis occurred in the BC-treated group.
We designed an AuNP-S-β-CD which can be a deliv-
ery vector for BC by serving as an inclusion complex.
The conjugated complexes were fully characterized by
TEM, 1H NMR, and UV-vis spectroscopy. In this study,
we manufactured 30-nm-diameter AuNPs which have
no inherent toxicity towards the body [33]. The AuNPs
were conjugated with S-β-CD in order to provide for in-
clusion of BC. Figure 3a shows that the AuNPs had a
spherical shape. The OH terminal groups of β-CD were
substituted with a thiol group in order to allow for con-
jugation to the AuNPs. The substituted β-CD demon-
strated SH peak in the 1H NMR graph (Fig. 3b). The
thiol group of the β-CD enables bonding of β-CD with
AuNP [34]. We confirmed S-β-CD conjugation to
AuNPs by using UV-vis spectroscopy (Fig. 3c). The max-
imum absorbance of the control AuNPs group was
found to occur at 525 nm. For the AuNP-S-β-CD group,
the maximum absorbance shifted to the right (533 nm)
as compared with the AuNPs group. This shift in the
maximum absorbance wavelength indicates successful
attachment of the S-β-CD on AuNPs [35]. We sonicated
BC with AuNP-S-β-CD in order to generate the AuNP-
S-β-CD-BC complex and confirmed that approxima-
tively 40 μM BC was loaded onto the AuNP-S-β-CD
(Fig. 3d).
The AuNP-S-β-CD-BC group also demonstrated in-
hibitory effects against MCF-7 cells after 48 h of incuba-
tion (Fig. 4a). The proliferation of MCF-7 cells was
significantly inhibited by the loaded BC released from
Fig. 1 Evaluation of cell viability in MCF-7 cells using cell counting kit (a) and live and dead cell assay (b). Single asterisk indicates significant
difference of p < 0.05, double asterisks indicate significant difference of p < 0.001 (N = 3)
Fig. 2 Fluorescent images of MCF-7 cells (a, b) under apoptosis. DNA fragmentation induced by BC as determined by gel electrophoresis (c)
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Fig. 3 TEM image of gold nanoparticles (a), 1H NMR graph of S-β-CD (b), absorbances of AuNP and AuNP-S-β-CD (c), absorbance spectra of BC
and AuNP-SH-β-CD-BC (d) as measured by UV-vis spectroscopy
Fig. 4 Anti-proliferation effects of AuNP-S-β-CD-BC against MCF-7 cells (a) the expression of cleaved caspase-3, full cleaved caspase-3, and Apaf-1
signals as measured from samples treated with AuNP-S-β-CD and AuNP-S-β-CD-BC (b). Single asterisk indicates significant difference of p < 0.05,
double asterisks indicate significant difference of p < 0.001 (N = 3)
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the AuNP-S-β-CD. When apoptosis occurs in cancer
cells, the apaf-1 signal is expressed. Subsequently, the
full-length caspase-3 signal decreases and the cleaved
caspase-3 signal increases [36]. The western blot assay
results demonstrate that apoptosis occurs in AuNP-S-β-
CD-BC group cells (Fig. 4b). Apaf-1 and cleaved
caspase-3 bands from the AuNP-S-β-CD-BC groups
were observed to have a higher intensity as compared
with AuNP-S-β-CD alone and control group. These re-
sults demonstrate that the BC complexed onto AuNP-S-
β-CD-induced apoptosis of MCF-7 cells.
Conclusions
We prepared AuNP-S-β-CD-BC complex for delivery of
BC as a chemotherapeutic strategy. Spherical AuNPs,
30 nm in diameter, were successfully conjugated with S-
β-CD. Subsequently, BC was complexed onto these
AuNP-S-β-CD. The anti-proliferation effectiveness of
the AuNP-S-β-CD system complexed with BC was con-
firmed using MCF-7 cells. All the results indicated that
BC from this system could induce apoptosis of MCF-7
cells. Although future studies will be necessary to con-
firm anti-cancer effects on the in vivo animal studies,
these findings and previous studies reporting the func-
tionalized gold nanoparticle for drug delivery system
suggest that the baicalin loaded AuNPs are effective ma-
terials for anti-cancer treatment.
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